|
|||
|
Welkom op de webpagina van clinical genomics!
Sinds januari 2001 is dit de webpagina van de Sectie Clinical
Genomics.
Since January 2001, this is the web page of the Department of
Clinical Genomics.
New
developments at the Genome Center Maastricht (GCM)2006 Alma-Grid:A virtual Lab for the Euregio As cofounder of the Interreg Alma-GRID project (www.alma-grid.eu) the Genome Center will further extend and optimize its infrastructure and stimulate collaborations with sister universities in the Euregion Meuse-Rhine. The alma-grid project aims at establishing a virtual lab and scientific community in this Euregion in order to use expensive, complementary infrastructure and expertise more efficiently and to provide services in the field of genomics, proteomics and bioinfomatics. Investments are being carried out as part of the project in a computer GRID and in software (LIMS). This LIMS of Labvantage (www.labvantage.com) will be the backbone of the project and will facilitate exchanges within the Euregional scientific community. Investigators or laboratories interested to join this initiative or the LIMS application, please feel free to contact us, as we aim to make the scientific community as big and lively as possible. Sequencing and resequencing The purchase of a new ABI3730 sequencer due to the joint efforts of university and hospital has increased the sequencing capacity and reduced costs and prices considerably. We are currently automating the entire sequencing pipeline and implementing DNA isolation and pipetting robots to increase sequencing throughput. New software tools, like Mutation Surveyor, for sequence and MLPA analysis allow a much easier and faster interpretation of data. A major breakthrough has been the implementation of Affymetrix resequencing CHIPs for the mitochondrial DNA (mtDNA). We are currently negotiating to analyze this year about 600 mtDNA CHIPs of €170 each for clinical service and collaborative research.
Protein assays – 96-well luminometer The GCM has with the support of the research institutes GROW and CARIM purchased a 96-well luminometer to measure bioluminescence (mainly luciferase). The major advantage of a luminometer is its superior sensitivity. A logic extension of transcription profiling work using microarrays includes the functional characterization of promoters that coordinately respond to the particular perturbations that were the focus of the microarray experiment. In such settings it is clear that a higher throughput will spare time and reagents. A medium throughput experiment involving the effect of 500 siRNAs would require less that an hour of measurement time enabling these kind of experiments.
GCM steps into the proteomics field with PamChip kinase profiling The Genome Center Maastricht has at its disposal a PamStation™ 4, a fully automated 4-array system designed for processing PamChip® 4 Arrays. It is ideal for low to medium sample throughput applications and assay development. The ‘heart’ of PamChip technology is the use of sheets of a micro porous material as the solid support for manufacturing microarrays. This material contains millions of 0.2 x 60 micron pores in parallel orientation connecting the top and bottom surfaces. Peptides or antibodies or other proteins are pre-coupled to the large internal surfaces of these pores. Samples containing proteins (or nucleic acid target molecules) are actively “pulsed” backwards and forwards through these pores where they interact by modifying or binding the immobilized peptides or proteins. Such “pulsing”, combined with minimization of diffusion distances, means that equilibration of binding is significantly speeded up. The result is that binding is reduced from hours to minutes depending on the application. In general, monitoring of this binding is possible in real-time, which means that kinetic information is gained for each interaction in question. It is possible to generate up to 400 kinetic curves for each array/sample in parallel. There are two “of the shelve” PamChip kinase profiling arrays available, one with peptide substrates derived from genuine tyrosine phosphorylated proteins and one for serine/threonine phosphorylated proteins. The tyrosine kinase array contains 144 peptide substrates for tyrosine kinases that can be interrogated independently for their phosphorylation status. Samples of pure kinases or extracts containing tyrosine-kinase activity are actively “pulsed” backwards and forwards through the pores of the arrays. These samples, in presence of ATP, phosphorylate the immobilized peptide substrates. Furthermore, the effect of varying additional parameters (temperature, salt, presence of inhibitory or competing ligands, etc.) can be interrogated in real-time. This enabling technology has several applications in proteomics: both protein profiling (detection of the presence of members of a sub-proteome in a complex mixture) and functional proteomics.
The Genome Center has expanded the Genotyping Unit with an ABI7900HT Taqman. This 384-well Real-Time PCR system is suitable for singleplex SNP-assays in 5µl reaction volumes, which leads to a significant reduction of the cost per sample compared to 96-well based systems. The costs of a typical assay is currently estimated at about €0.30 - €0.35 per SNP genotype. Furthermore, over 2 million SNP assays are already available through the website of Applied Biosystems (Taqman SNP Assays). The Taqman assays are designed and produced by Applied Biosystems and contain 2 PCR primers and 2 allele specific probes. Normally, the assays can be delivered within 2 weeks after ordering. Applied Biosystems will give a refund if assays are not functional. The small scale assay contains enough material for about 1500 samples. The ABI7900HT is therefore suited for projects in which a few hundred to thousands of samples have to be genotyped for a limited number of SNPs.
With respect to the Alma-Grid project (mentioned above), we shall be shortly increasing our computer power from eight processors to a Computer Cluster of more than 25 processors including a super computer with 64GB of memory. This will more than triple our current analysis capacity and allow us to perform analysis of large scale experiments.
July 17, 2006 ________________________________________________________________________________________________________________
New
developments at the Genome Center Maastricht (GCM) 2005
The Genome Center is pleased to announce a number of important new developments that will significantly increase our capabilities to support genomics researchers of the UM and azM.
Affymetrix
Megallele:
Pamgene:
Contact Information:
Bioinformatics and Genetic Epidemiology Unit: Patrick Lindsey ( patrick.lindsey@gen.unimaas.nl) SNP Genotyping and Sequencing Unit: Bert Smeets (bert.smeets@molcelb.unimaas.nl)
Kind regards, ______________________________________________________________________________________________________________________ Het GenoomCentrum Het GenoomCentrum is een uitvloeisel van de BOS en is ondergebracht bij de afdeling populatiegenetica. De doelstellingen zijn het opzetten van toonaangevend Genomics-onderzoek binnen de participerende instituten en het, hetzij technisch (methoden, infrastructuur), hetzij inhoudelijk, ondersteunen van onderzoeksgroepen, die Genoom en Populatiegenetisch onderzoek overwegen of uitvoeren. Opgezet worden:
The Genome Center Genome Center Newsletter February 1, 2001 [MS Word format] February 1, 2001 [Adobe Acrobat format] October 3, 2001 [MS Word format] October 3, 2001 [Adobe Acrobat format] September 11, 2002 [MS Word format] September 11, 2002 [Adobe Acrobat format] June 2, 2003 [MS Word format] June 2, 2003 [Adobe Acrobat format] August 21, 2003 [MS Word format] August 21, 2003 [Adobe Acrobat format] October
7, 2003 [MS Word format]
|
|||